WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with ...

Teleflex Incorporated has announced a contract with Vizient, Inc. for the supply of its Central Venous Access Catheters and Arterial Catheters, effective January 1, 2025. Vizient, the largest provider ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

No-moat Teleflex’s TFX third-quarter results came mostly in line with our expectations. We are maintaining our $211 fair value estimate, and the shares appear about fairly valued. Management raised ...

As of Thursday, February 26, Teleflex Incorporated’s TFX share price has surged by 7.09%, which has investors questioning if this is right time to sell.

Teleflex focuses on the sale of medical technology products, generally used in hospitals and health centers. I think that development and innovation in new products, expansion of technologies, and the ...

Limerick, Pa.-based Teleflex, a global provider of medical devices for critical care and surgery, announced it will showcase its regional anesthesia and pain management products during the ESRA ...

Over the past decade, Teleflex has transformed from a diverse industrial, commercial, and healthcare company to one focused on single-use medical devices using the dual levers of acquisitions and ...

Teleflex faces a complex transition after divesting major business units at low multiples, creating uncertainty around future ...

WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced ...